Supplementary Table S4 from Jak2<sup>V617F</sup> Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms
Andrew Dunbar(Memorial Sloan Kettering Cancer Center), Ross L. Levine(Memorial Sloan Kettering Cancer Center), Max Brodsky(Memorial Sloan Kettering Cancer Center), Inés Fernández-Maestre(Memorial Sloan Kettering Cancer Center), Mirko Farina(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Shoron Mowla(Memorial Sloan Kettering Cancer Center), Young C. Park(Memorial Sloan Kettering Cancer Center), Won Jun Kim(Kettering University), Tamara Codilupi(Department of Biomedicine Basel), Michael R. Waarts(Cancer Services), Franco Izzo(Fred Hutch Cancer Center), Anthony R. Martinez Benitez(Memorial Sloan Kettering Cancer Center), Jacob L. Glass(Memorial Sloan Kettering Cancer Center), Amritha Varshini Hanasoge Somasundara(Memorial Sloan Kettering Cancer Center), Robert L. Bowman(University of Pennsylvania), Aaron D. Viny(Columbia University Irving Medical Center), Zachary Zaroogian(Memorial Sloan Kettering Cancer Center), Shira E. Eisman(Memorial Sloan Kettering Cancer Center), Wenbin Xiao(Memorial Sloan Kettering Cancer Center), Emily Guzzardi(Memorial Sloan Kettering Cancer Center), Abbas Nazir(Memorial Sloan Kettering Cancer Center), Richard P. Koche(Massachusetts General Hospital), Remie Houston(Memorial Sloan Kettering Cancer Center), Tanmay Mishra(Vellore Institute of Technology University), Benjamin Wang(Memorial Sloan Kettering Cancer Center), Robert M. Myers(Memorial Sloan Kettering Cancer Center), Abdul Karzai(Memorial Sloan Kettering Cancer Center), Wenbin An(Chinese Academy of Medical Sciences & Peking Union Medical College), Louise Cai(Memorial Sloan Kettering Cancer Center), Sheng F. Cai(Memorial Sloan Kettering Cancer Center), Dan A. Landau(Cornell University), Sara C. Meyer(University of Bern), Kavi O’Connor(Memorial Sloan Kettering Cancer Center), Julie L. Yang(Memorial Sloan Kettering Cancer Center)
Cited by 0
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k